Hearing loss in congenital toxoplasmosis detected by newborn screening;Deficiência auditiva na toxoplasmose congênita detectada pela triagem neonatal

Brazilian Journal of Otorhinolaryngology

Volumn 74, Issue 1, 2008, Pages 21-28

  De Andrade, Gláucia Manzan Queiroz ^a,b,e   De Resende, Luciana Macedo ^a,e   Goulart, Eugênio Marcos Andrade ^a,e   Siqueira, Arminda Lucia ^b,c,e   Vitor, Ricardo Wagner De Almeida ^d,e   Januario, José Nelio ^a,e  

^a FM UFMG

^b NUPAD ^*

^c UFMG

^d ICB UFMG

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Congenital toxoplasmosis; Hearing loss; Newborn screening

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE; SULFADIAZINE; PROTOZOON ANTIBODY;

ARTICLE; AUDIOLOGY; AUDIOMETRY; BIRTH WEIGHT; BRAZIL; CONGENITAL TOXOPLASMOSIS; EVOKED BRAIN STEM RESPONSE; EVOKED OTOACOUSTIC EMISSION; HEARING IMPAIRMENT; HEARING LOSS; HEARING TEST; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PERCEPTION DEAFNESS; PROSPECTIVE STUDY; RISK FACTOR; SEROLOGY; ANIMAL; BLOOD; FEMALE; HOSPITALIZATION; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; PRESCHOOL CHILD; TOXOPLASMA;

ANIMALS; ANTIBODIES, PROTOZOAN; CHILD, PRESCHOOL; FEMALE; HEARING LOSS; HEARING TESTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 48849117339     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1016/S1808-8694(15)30746-1     Document Type: Article

References (28)

1. Joint Committee on Infant Hearing. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Am J Audiol. 2000;9:9-29.
2. Isaac ML, Manfredi AKS. Diagnóstico precoce da surdez na infância. Medicina (Ribeirão Preto) 2005;38(3/4):235-44.
3. Nobrega Md, Weckx LLM, Juliano Y. Study of the hearing loss in children and adolescents, comparing the periods of 1990-1994 and 1994-2000. Int J Pediatr Otorhinolaryngol 2005;69:829-38.
4. Cecatto SB, Garcia RID, Costa KS, Abdo TRT, Rezende CEB, Rapoport PB. Análise das principais etiologias de deficiência auditiva em Escola Especial "Anne Sullivan". Rev Bras Otorrinolaringol 2003;69(2):235-40.
5. Lima GML, Marba STM, Santos MFC. Hearing screening in a neonatal intensive care unit. J Pediatr (Rio J) 2006;82(2):110-4.
6. Walch C, Anderhuber W, Köle W, Berghold A. Bilateral sensorineural hearing disorders in children: etiology of deafness and evaluation of hearing tests. Int J Pediatr Otorhinolaryngol 2000;53:31-8.
7. Stagno S, Britt W. Cytomegalovirus Infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 739-81.
8. Silva AA, Maudonnet O, Panhoca R. A deficiência auditiva na infância. Retrospectiva de dez anos. ACTA AWHO 1995;14(2):72-5.
9. Cóser PL, Vilanova LCP. Rubéola materno-fetal: avaliação da perda auditiva por audiometria de tronco cerebral. Rev Bras Otorrinolaringol 1996;62(5):366-74.
10. Kadoya R, Ueda K, Miyazaki C, Hidaya Y, Tokugawa K. Incidence of congenital rubella syndrome and influence of the rubella vaccination program for schoolgirls in Japan, 1981-1989. Am J Epidemiol 1998;148(3):263-8.
11. Arvin AM, Whitley RJ, Gutierrez KM. Herpes Simplex Virus Infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 845-65.
12. Matas CG, Sansone AP, Iorio MCM, Succi RCM. Avaliação audiológica em crianças nascidas de mães soropositivas para o vírus da imunodeficiência humana. Rev Bras Otorrinolaringol 2000;66(4):317-24.
13. Wright I. Congenital toxoplasmosis and deafness. An investigation. Pract Otorhinolaryngol (Basel) 1971;33(6):377-87.
14. Kelemen G. Toxoplasmosis and Congenital Deafness. A M A Arch Otolaryngol 1958;68:547-61.
15. McGee T, Wolters C, Stein L, Kraus N, Johnson D, Boyer K, et al. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngol Head Neck Surg 1992;106(1):75-80.
16. Muhaimeed HA. Prevalence of sensorineural hearing loss due to toxoplasmosis in Saudi children: a hospital based study. Int J Pediatr Otorhinolaryngol 1996;34:1-8.
17. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 947-1091.
18. Wilson CB, Desmonts G, Couvreur J, Remington JS. Lymphocyte transformation in diagnosis of congenital Toxoplasma infection. the N Engl J Med 1980;302:785-8.
19. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66(5):767-74.
20. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 2006;42(10):1383-94.
21. Potasman I, Davidovitch M, Tal Y, Tal J, Zelnik N, Jaffe M. Congenital toxoplasmosis: a significant cause of neurological morbidity in Israel? Clin Infect Dis 1995;20(2):259-62.
22. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert R, Dutton GN, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996;15:799-805.
23. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994;18(1):38-72.
24. Gorga MP, Kaminski JR, Beauchaine KA, Jesteadt W, Neely ST. Auditory brainstem responses from children three months to three years of age: II. Normal patterns of response. J Speech Hear Res 1989;32:281-8.
25. Azevedo MF, Pereira LD, Vilanova LCP, Goulart AL. Avaliação do processamento auditivo central: identificação de crianças em risco para alteração da linguagem e aprendizado durante o primeiro ano de vida. In: Marchesan IQ, Bolaffi C, Gomes ICD, Zorzij L, editors. Tópicos em fonoaudiologia. São Paulo: Lovise; 1995. p. 447-62.
26. Gravel JS, White KR, Johnson JL, Widen JE, Vohr BR, James M, et al. A multisite study to examine the efficacy of the Otoacoustic Emission/Automated Auditory Brainstem Response newborn hearing screening protocol: recommendations for policy, practice and research. Am J Audiol. 2005;14:S217-S28.
27. Carvalho AL. Estudo de 114 casos de toxoplasmose congênita acompanhados no setor de infectologia pediátrica do Departamento de Pediatria, FM-UFMG, no período de 1982-1996. [Dissertação (Mestrado)]. Belo Horizonte: Universidade Federal de Minas Gerais;2001.
28. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994;18:38-72.